Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection

Infection

Volumn 40, Issue 3, 2012, Pages 331-334

  Bartalesi, F ^a   Veloci, S ^b   Baragli, F ^b   Mantengoli, E ^b   Guidi, S ^a   Bartolesi, A M ^a   Mannino, R ^a   Pecile, P ^a   Bartoloni, A ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bloodstream infection; Central venous catheter; Lactobacillus rhamnosus; Lock therapy; Tigecycline

Indexed keywords

ACETYLCYSTEINE; AMPICILLIN; CD20 ANTIBODY; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; PENICILLIN G; RITUXIMAB; RNA 16S; TACROLIMUS; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; FEVER; HUMAN; LACTOBACILLUS RHAMNOSUS; LARGE CELL LYMPHOMA; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LOADING DRUG DOSE; MALNUTRITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; RNA SEQUENCE; SEPSIS; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TOTAL PARENTERAL NUTRITION; WEIGHT REDUCTION;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LACTOBACILLUS RHAMNOSUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TREATMENT OUTCOME;

EID: 84864286452     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0196-3     Document Type: Article

References (21)

1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
2. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME. Saint S; Healthcare Infection Control Practices Advisory Committee Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39:S1-34.
3. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645-57.
4. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a reviewof the literature.Ann Pharmacother. 2005;39:311-8.
5. Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S. Treatment of longterm intravascular catheter-related bacteraemia with antibioticlock therapy. J Antimicrob Chemother. 2006;58:816-21.
6. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheterrelated bacteraemia with antibiotic lock: randomized, placebocontrolled trial. J Antimicrob Chemother. 2005;55:90-4.
7. Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. J Parenter Enteral Nutr. 2002;26:109-13.
8. Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. J Parenter Enteral Nutr. 2002;26:104-8.
9. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother. 2003;47:3145-8.
10. Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibioticlock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother. 2005;49:4042-5.
11. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother. 2007;51:78-83.
12. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia. Infect Control Hosp Epidemiol. 2008;29:894-7.
13. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillinresistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007;51:1656-60.
14. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother. 2009;43:210-9.
15. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16s ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 1990;28:1942-6.
16. Clinical and Laboratory Standards Institute: Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria: approved guideline. CLSI document M45-A. Clinical and Laboratory Standards Institute, Wayne; 2008.
17. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:35-44.
18. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents. Antimicrob Agents Chemother. 2006;50:3507-13.
19. Aslam S, Trautner BW, Ramanathan V, Darouiche RO: Combination of Tigecycline and N-Acetylcysteine reduces biofilmembedded bacteria on vascular catheters. Antimicrob Agents Chemother. 2007;51:1556-8.
20. Cafiso V, Bertuccio T, Spina D, Purrello S, Stefani S. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus: comparison with other drugs. FEMS Immunol Med Microbiol. 2010;59:466-9.
21. Messing B, Peitra-Cohen S, Debure A, et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988;12:185-9.